OSCR

Magnesium Transporter SLC41A1 Links Magnesium Homeostasis to NMDA Receptor-Related Synaptic Dysfunction: A Transdiagnostic Therapeutic Target for Neuropsychiatric Disorders.

Overview

Authors: Xinru Chen1,2, Wenhao Deng1,2, Xinrui Chen1,3, Yang Yu1,4
ORCID iDs: Xinru Chen
  1. Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou 510370, China; (X.C.); (W.D.); (X.C.)
  2. The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou 510370, China
  3. Department of Clinical Psychology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou 510370, China
  4. Institute of Psycho-Neuroscience, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou 510370, China
Institutions: Guangzhou Medical University (China)
Journal: Biomedicines, volume 14, issue 3, article 610
Dates: received 13 December 2025; accepted 5 March 2026; published online 9 March 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3390/biomedicines14030610 · PMID 41898257 · PMCID PMC13024283 · OpenAlex W7134279860
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: genetics / omics (modality), cellular / molecular (subfield)
Methods: Statistics, Connectivity
Keywords: neuropsychiatric disorders, SLC41A1, causal inference, multi-omics, magnesium homeostasis, NMDA receptor
Topic: Magnesium in Health and Disease (Nutrition and Dietetics, Nursing), according to OpenAlex
Funding: Guangdong Basic and Applied Basic Research Foundation (2021A1515011322)
Citations: not cited yet (Europe PMC); 55 references in the paper

Abstract

Background: Neuropsychiatric disorders such as Alzheimer’s disease (AD), bipolar disorder (BD), and depression exhibit shared glutamatergic abnormalities, although their upstream molecular mechanisms remain poorly defined. Magnesium (Mg2+) serves as a key regulator of N-methyl-D-aspartate (NMDA) receptor function; however, the role of Mg2+ transporters, particularly SLC41A1, has not been systematically investigated. As NMDA receptor dysregulation contributes to emotional and cognitive impairments, elucidating Mg2+-NMDA signaling may enable the development of novel therapeutic strategies. Methods: We integrated Mendelian randomization, locus colocalization, human brain transcriptomics, functional enrichment, and co-expression analyses to determine whether SLC41A1 functions as a cross-disorder molecular driver. In addition, in vitro electrophysiological experiments using field potential recordings in hippocampal Schaffer-CA1 synapses were conducted to validate its functional role in NMDA receptor-mediated synaptic transmission. Results: Genetically elevated SLC41A1 expression increased the risk of AD, BD, depression, and alcohol dependence, with strong colocalization analyses supporting shared causal variants. Transcriptomic profiling revealed SLC41A1 upregulation in AD and BD, with enrichment in magnesium transport, mitochondrial function, and synaptic signaling pathways. Co-expression networks across GTEx brain regions demonstrated strong correlations with NMDA-related genes (e.g., GRINA, CAMK2G, GRIN2C). Under NMDAR-selective recording conditions, both imipramine treatment and SLC41A1 knockdown significantly reduced NMDAR-mediated fEPSP amplitudes, supporting a role for SLC41A1 in regulating NMDA receptor-dependent synaptic responses. Conclusions: This study identifies SLC41A1 as a magnesium-centered, transdiagnostic therapeutic target that links Mg2+ homeostasis to NMDA-dependent synaptic dysfunction. These findings provide a mechanistic foundation for developing SLC41A1-modulating or magnesium-based therapeutic approaches for mood and cognitive disorders.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The datasets used in this study are available from public online repositories. Access details and accession numbers can be found in the article or Supplementary Materials. Animal data are available upon reasonable request from the corresponding author.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 4 authors, 6 keywords, 1 funder, 55 references.

Cite

This paper

Chen, X., Deng, W., Chen, X., & Yu, Y. (2026). Magnesium Transporter SLC41A1 Links Magnesium Homeostasis to NMDA Receptor-Related Synaptic Dysfunction: A Transdiagnostic Therapeutic Target for Neuropsychiatric Disorders. Biomedicines, 14(3), 610. https://doi.org/10.3390/biomedicines14030610

BibTeX

@article{chen2026magnesium,
author = {Chen, Xinru and Deng, Wenhao and Chen, Xinrui and Yu, Yang},
title = {{Magnesium Transporter SLC41A1 Links Magnesium Homeostasis to NMDA Receptor-Related Synaptic Dysfunction: A Transdiagnostic Therapeutic Target for Neuropsychiatric Disorders}},
journal = {Biomedicines},
year = {2026},
month = mar,
volume = {14},
number = {3},
pages = {610},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2227-9059},
doi = {10.3390/biomedicines14030610},
url = {https://doi.org/10.3390/biomedicines14030610},
pmid = {41898257},
pmcid = {PMC13024283}
}

RIS

TY - JOUR
AU - Chen, Xinru
AU - Deng, Wenhao
AU - Chen, Xinrui
AU - Yu, Yang
TI - Magnesium Transporter SLC41A1 Links Magnesium Homeostasis to NMDA Receptor-Related Synaptic Dysfunction: A Transdiagnostic Therapeutic Target for Neuropsychiatric Disorders
T2 - Biomedicines
J2 - Biomedicines
PY - 2026
DA - 2026/03/09
VL - 14
IS - 3
SP - 610
SN - 2227-9059
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/biomedicines14030610
UR - https://doi.org/10.3390/biomedicines14030610
LA - en
ER -

CSL-JSON

{
"id": "10.3390/biomedicines14030610",
"type": "article-journal",
"title": "Magnesium Transporter SLC41A1 Links Magnesium Homeostasis to NMDA Receptor-Related Synaptic Dysfunction: A Transdiagnostic Therapeutic Target for Neuropsychiatric Disorders",
"container-title": "Biomedicines",
"author": [
{
"family": "Chen",
"given": "Xinru"
},
{
"family": "Deng",
"given": "Wenhao"
},
{
"family": "Chen",
"given": "Xinrui"
},
{
"family": "Yu",
"given": "Yang"
}
],
"container-title-short": "Biomedicines",
"volume": "14",
"issue": "3",
"page": "610",
"DOI": "10.3390/biomedicines14030610",
"PMID": "41898257",
"PMCID": "PMC13024283",
"ISSN": "2227-9059",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/biomedicines14030610",
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
9
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s44184-026-00232-3
Integrated proteomic, transcriptomic, and epigenomic profiling identifies SRA1 as a novel therapeutic target for postpartum depression.
Journal: Npj mental health research
In common: genetics / omics, 7 references
[2] doi:10.1371/journal.pcbi.1014422 [code]
Deciphering cell type-specific causal genetic effects on brain imaging-derived phenotypes and disorders with single-cell Mendelian randomization.
Journal: PLoS computational biology
In common: genetics / omics, cellular / molecular, 6 references
[3] doi:10.1038/s41593-026-02247-7 [code]
Transcriptomic and phenotypic convergence of neurodevelopmental disorder risk genes in vitro and in vivo.
Journal: Nature neuroscience
In common: genetics / omics, cellular / molecular, 6 references
[4] doi:10.1038/s41588-026-02646-3 [code]
Co-expression-based models improve eQTL predictions for transcriptome-wide association studies and highlight new schizophrenia-associated genes.
Journal: Nature genetics
In common: genetics / omics, cellular / molecular, 5 references
[5] doi:10.1038/s41380-026-03497-4 [code]
Transcriptome-informed brain cartography of polygenic risk and association with brain structure in major psychiatric disorders.
Journal: Molecular psychiatry
In common: genetics / omics, cellular / molecular, 4 references
[6] doi:10.1038/s42003-026-10045-x [code]
Spatiotemporal brain transcriptomics reveal risk gene hot-spots in major neuropsychiatric disorders.
Journal: Communications biology
In common: genetics / omics, cellular / molecular, 4 references
[7] doi:10.1007/s00406-026-02302-1 [code]
Exploring the genetic correlation between inflammatory bowel disease and psychiatric disorders: insights from genome-wide association studies.
Journal: European archives of psychiatry and clinical neuroscience
In common: genetics / omics, cellular / molecular, 4 references
[8] doi:10.3389/fneur.2026.1794851
Mitochondrial protein alterations in vascular dementia: evidence from Mendelian randomization, transcriptomics, and a chronic hypoperfusion model.
Journal: Frontiers in neurology
In common: NCBI GEO GSE122063, genetics / omics, cellular / molecular
[9] doi:10.1038/s41467-026-71542-5 [code]
Astrocyte fatty acid metabolism as a driver of risk for major depressive disorder.
Journal: Nature communications
In common: genetics / omics, cellular / molecular, 4 references
[10] doi:10.3389/fnagi.2026.1855522
Astragaloside IV attenuates hypoxia-reoxygenation-induced endothelial senescence and vascular inflammation by modulating the NOTCH1/VCAM-1 axis.
Journal: Frontiers in aging neuroscience
In common: NCBI GEO GSE122063, cellular / molecular

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.